KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$11.2 million.

  • BioNTech SE's Gains from Investment Securities fell 73870.02% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$252.9 million, marking a year-over-year increase of 899.51%. This contributed to the annual value of -$415.9 million for FY2024, which is 1995.38% up from last year.
  • As of Q3 2025, BioNTech SE's Gains from Investment Securities stood at -$11.2 million, which was down 73870.02% from -$16.9 million recorded in Q2 2025.
  • BioNTech SE's 5-year Gains from Investment Securities high stood at $476.2 million for Q2 2023, and its period low was -$4.0 billion during Q4 2021.
  • Over the past 5 years, BioNTech SE's median Gains from Investment Securities value was -$16.9 million (recorded in 2025), while the average stood at -$494.5 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 120027550369638.28% in 2022, then surged by 15638.89% in 2023.
  • BioNTech SE's Gains from Investment Securities (Quarter) stood at -$4.0 billion in 2021, then soared by 64.21% to -$1.4 billion in 2022, then soared by 95.05% to -$70.0 million in 2023, then tumbled by 202.68% to -$212.0 million in 2024, then surged by 94.71% to -$11.2 million in 2025.
  • Its Gains from Investment Securities was -$11.2 million in Q3 2025, compared to -$16.9 million in Q2 2025 and -$12.8 million in Q1 2025.